Injective jumps 27% in a day, leaving NEAR and Sei behind
INJ's surge highlights potential market shifts as ETF approvals could broaden investor access, impacting supply dynamics and valuation.
시장이 처음이라면 — 가격, 수익률, market cap? 브라우징하면서 모든 용어를 평이한 영어로 설명합니다. 동일한 데이터에 도움말이 내장된 방식입니다.
시장은 이미 알고 있다고 가정합니다. 데이터만 — 깔끔하고 빠르며 간결하게, 별도의 설명 없이 제공합니다. 기본 보기입니다.
이 사이트의 모든 수치는 해당 기간 및 출처와 함께 JSON 형식으로 제공됩니다.
API 문서 읽기뉴스룸을 보유한 언론사에서 이 자산을 다룬 헤드라인입니다. 가격 전망 형식으로 작성된 기사는 이 페이지에 도달하기 전에 필터링됩니다.
INJ's surge highlights potential market shifts as ETF approvals could broaden investor access, impacting supply dynamics and valuation.
Injective continued its rebound on Friday, trading around $9.25 as improving momentum and declining exchange balances supported a constructive outlook.
Long-term investors will want to see prices climb past $13.575 comfortably before looking for signs of a long-term trend shift.
Injective has rallied more than 8% on October 16, reaching $9.35 as increased trading activity and renewed interest in the network's institutional developments have…
Injective records significant gains as Gulf Labs joined its institutional validators with its trading volume and open interest spiking sharply recently.
Injective's integration of tokenized assets could revolutionize financial markets by enhancing accessibility and regulatory compliance on-chain.
Injective's fixed gas fees could enhance DeFi trading efficiency, offering cost predictability and potentially attracting more high-frequency traders.
Injective's partnership with Gulf Labs could significantly enhance its presence in Asia, potentially transforming Thai financial sectors.
Injective's quantum-resistant infrastructure development could enhance blockchain security, influencing future cryptographic standards.
Tokens left exchanges as derivatives exposure grew. Are holders settling in while traders chase the rally?
The Injective Trench Treasury's launch signifies a strategic shift towards rewarding sustainable community-driven projects, fostering long-term ecosystem growth.
Injective ecosystem saw two major developments; Injective Foundation launched the Trench Treasury while Canary Capital filed with the SEC for Staked INJ ETF.
There are currently three INJ ETF applications: the 21Shares Injective ETF, the Canary Staked INJ ETF, and the REX-Osprey INJ Staking ETF.
The advancing ETF applications could enhance INJ's market presence, potentially influencing broader crypto investment trends and regulatory landscapes.
RUNNER's innovative treasury strategy could significantly impact token supply dynamics, linking its value closely to INJ's market performance.
Injective's CypherOS demo highlights the growing demand for privacy in blockchain, potentially reshaping institutional trading dynamics.
Injective's Stockdrop could revolutionize equity access, offering decentralized, 24/7 trading and potentially reshaping traditional markets.
Canary Capital amended its staked Injective ETF filing with the U.S. Securities and Exchange Commission (SEC).
Injective has confirmed that Injective CypherOS, a native on-chain privacy layer, is coming to the network.
The Meridian upgrade positions Injective as a compliance-native blockchain, potentially boosting institutional adoption and INJ token demand.
Injective's collaboration with Microsoft could accelerate AI-blockchain integration, potentially transforming digital commerce and financial systems.
The SEC's review of the 21Shares Injective ETF could accelerate mainstream adoption of altcoins, impacting market dynamics and investor strategies.
The crypto market has seen over $630 million liquidated in the past 24 hours after the Clarity Act vote sentiment shift.
Injective's growth in RWA perpetual markets highlights a shift towards 24/7 synthetic trading, challenging traditional market structures.
Injective's upgrade enhances regulatory compliance and interoperability, potentially positioning it as a leader in tokenized securities.
Injective's blockchain dominance in tokenized real estate could reshape asset management, but reliance on Pineapple poses concentration risks.
Injective soared 13%, flipped $6 resistance, and climbed to a three-month high of $6.7.
Injective's privacy initiative could redefine blockchain's role in institutional finance, balancing confidentiality with regulatory compliance.
The mortgage lender plans to bring more than $10 billion in historical loans onchain, turning thousands of mortgage files into blockchain-based records.
Pineapple Financial's blockchain migration could revolutionize mortgage data transparency and risk assessment, setting a precedent for the industry.